v3.26.3
Stock-Based Compensation (Tables)
 6 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation
The following table provides information regarding our stock-based compensation:
Three Months Ended September 30,Six Months Ended September 30,
(In thousands)2026202520262025
Pre-tax stock-based compensation costs charged against income$1,231 $1,767 $5,225 $5,449 
Income tax benefit recognized on compensation costs$196 $229 $703 $694 
Total fair value of options and RSUs vested during the period$1,059 $1,240 $10,025 $10,276 
Cash received from the exercise of stock options$94 $752 $94 $3,907 
Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises$297 $162 $647 $942 
Schedule of Restricted Shares A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:
 
 
 
RSUs
 
Shares
(in thousands)
Weighted
Average
Grant-Date
Fair Value
Six Months Ended September 30, 2025
Unvested at March 31, 2025402.2 $63.20 
Granted128.3 82.04 
Vested (128.6)57.61 
Forfeited(23.8)63.88 
Unvested at September 30, 2025378.1 71.45 
Vested at September 30, 2025110.2 43.14 
Six Months Ended September 30, 2026
Unvested at March 31, 2026379.1 $71.34 
Granted210.0 55.08 
Vested (118.0)65.57 
Forfeited(36.5)63.09 
Unvested at September 30, 2026434.6 65.74 
Vested at September 30, 2026103.7 45.38 
Schedule of Fair Value of Options Granted
The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:
Six Months Ended September 30,
20262025
Expected volatility
25.8% to 28.1%
28.4% to 30.1%
Expected dividends$— $— 
Expected term in years
6.0 to 7.0
6.0 to 7.0
Risk-free rate
4.3%
4.0% to 4.1%
Weighted average grant date fair value of options granted$18.88 $31.03 
Schedule of Stock Option Activity
A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:
 
 
 
 
Options
 
 
Shares
(in thousands)
Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Term (years)		Aggregate
Intrinsic
Value
(in thousands)
Six Months Ended September 30, 2025
Outstanding at March 31, 2025518.7 $52.22 
Granted109.7 82.58 
Exercised(70.5)55.41 
Forfeited(36.3)76.13 
Outstanding at September 30, 2025521.6 56.51 6.5$5,482 
Vested at September 30, 2025341.5 46.88 5.3$5,462 
Six Months Ended September 30, 2026
Outstanding at March 31, 2026500.3 $56.40 
Granted187.6 55.28 
Exercised(2.4)39.98 
Forfeited (7.0)64.28 
Expired(14.6)57.11 
Outstanding at September 30, 2026663.9 56.05 6.4$1,367 
Vested at September 30, 2026410.6 52.10 4.7$1,367